期刊文献+

LEP、TNF-α、CEA、CRP和IL-6在结核病与恶性肿瘤中的鉴别诊断价值 被引量:10

The differential diagnosis of LEP,TNF-α,CEA,CRP and IL-6 in tuberculosis and malignant tumors
在线阅读 下载PDF
导出
摘要 目的探讨胸腔积液及血清中瘦素(LEP)、癌胚抗原(CEA)、肿瘤坏死因子-a(TNF-a)、白细胞介素-6(IL-6)及C反应蛋白(CRP)在诊断鉴别肺癌及肺结核疾病中的临床价值。方法 2013年6月至2014年6月选取60例肺结核及60例肺癌患者为研究对象,分别应用酶联免疫法及免疫比浊法分别测定两组患者血清及胸腔积液中LEP、CEA、TNF-a、IL-6及CRP水平。结果肺癌组患者胸腔积液、血液中LEP、CEA、TNF-a水平均高于肺结核组(P<0.05),而IL-6水平低于肺结核组(P<0.05),两组血清及胸腔积液中CRP水平均无统计学差异(P>0.05)。血清及胸腔积液中4种相关因子联合检测灵敏性、特异性、阳性预测值、阴性预测值与各单项相比差异有统计学意义(P<0.05)。结论肺癌患者血清及胸腔积液中LEP、CEA、TNF-a水平均高于肺结核组,而IL-6水平则低于肺结核组。通过联合检测可提高相关因子的诊断灵敏性,有助于肺癌及肺结核患者的鉴别诊断。 Objective To investigate the clinical value of investigate pleural effusion and serum leptin (LEP),carci-noembryonic antigen (CEA),tumor necrosis factor-a (TNF-a),interleukin-6(IL-6)and C-reactive protein (CRP)in the differential diagnosis of lung cancer and pulmonary diseases.Methods The levels of LEP,CEA,TNF-a,IL-6 and CRP in serum and pleural effusion of 60 cases of tuberculosis and 60 cases of lung cancer patients were measured with ELISA and immunonephelometry.Results The levels of LEP,CEA,TNF-a in serum and pleural effusion of lung canc-er were higher than tuberculosis group (P〈0.05),while the levels of IL-6 of Tuberculosis group were lower than tu-berculosis groups(P〈0.05),the levels of CRP in serum and pleural statistically were significant difference (P〉0.05). The factor sensitivity,specificity,positive predictive value,negative predictive value of serum and pleural effusion were hihger than those in the single (P〈0.05).Conclusion The levels of pleural effusion LEP,CEA,TNF-a of patients with lung cancer were higher than the tuberculosis group,but lower than the level of IL-6 were lower than tuberculosis group.Through joint detection can improve the diagnostic sensitivity of the relevant factors to help in the differential di-agnosis of lung cancer and tuberculosis patients.
作者 王艳 陈璐
出处 《中国实验诊断学》 2014年第12期1993-1996,共4页 Chinese Journal of Laboratory Diagnosis
基金 南京医科大学科技发展基金(编号:2012NJMU238)
关键词 细胞因子类 胸腔积液 血清 肺癌 肺结核 cytokines pleural effusion serum lung cancer tuberculo
作者简介 通讯作者
  • 相关文献

参考文献12

二级参考文献45

共引文献87

同被引文献62

  • 1彭春仙,郑晓燕,范剑,童向民.趋化因子MCP-1、MSP联合癌胚抗原检测在肺结核与肺癌鉴别诊断中的意义[J].中华临床感染病杂志,2013,6(6):331-334. 被引量:7
  • 2刘妍丽,韩丹,陆兰英.CA125、ADA、CEA、CRP联合检测对胸腔积液的鉴别诊断价值[J].实用癌症杂志,2014,29(3):272-275. 被引量:4
  • 3顾爱琴,熊丽纹,忻宇,纪灏,包国良,韩宝惠.胸腺肽在晚期非小细胞肺癌化疗中的作用[J].中国癌症杂志,2007,17(6):493-495. 被引量:8
  • 4Siegel R,Naishadham D,Jemal A.Cancer statistics,2012.CA Cancer J Clin,2012,62:10-29.
  • 5Stathopoulos GT,Kalomenidis I.Animal models of malignant pleural effusion.Curr Opin Pulm Med,2009,15:343-352.
  • 6Nam HS.malignant pleural effusion:medical approaches for diagnosis and management.Tuberc Respir Dis(Seoul),2014,76:211-217.
  • 7Marulli G,Rea F,Nicotra S,et al.Effect of induction chemotherapy on lung function and exercise capacity in patients affected by malignant pleural mesothelioma.Eur J Cardiothorac Surg,2010,37:1464-1469.
  • 8Cunningham D,Okines AF,Ashley S.Capecitabine and oxaliplatin for advanced esophagogastric cancer.N Engl J Med,2010,362:858-859.
  • 9Tesniere A,Schlemmer F,Boige V,et al.Immunogenic death of colon cancer cells treated with oxaliplatin.Oncogene,2010,29:482-491.
  • 10Mir O,Boudou-Rouquette P,Giroux J,et al.pemetrexed,oxaliplatin and bevacizumab as first-line treatment in patients with stageivnon-small cell lung cancer.Lung Cancer,2012,77:104-109.

引证文献10

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部